Successful Treatment of Langerhans Cell Histiocytosis Complicated by Leukemia
Author Information
Author(s): Khalid A Al-Anazi, Abdulrahman Alshehri, Hazza A Al-Zahrani, Fahad I Al-Mohareb, Irfan Maghfoor, Dahish Ajarim
Primary Institution: King Faisal Specialist Hospital and Research Centre
Conclusion
High dose chemotherapy followed by an allogeneic stem cell transplant may be a curative option for patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia.
Supporting Evidence
- The patient developed therapy-related myelodysplastic syndrome and acute myeloid leukemia after treatment for LCH.
- High dose chemotherapy followed by an allogeneic stem cell transplant was performed.
- The patient achieved complete remission of leukemia after treatment.
Takeaway
A man with a rare disease called Langerhans cell histiocytosis got very sick from his treatment, but doctors helped him get better with a special transplant.
Methodology
The patient underwent chemotherapy and an allogeneic hematopoietic stem cell transplant after developing leukemia from previous treatments.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
A 34-year-old male from Saudi Arabia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website